Katy Moncivais, PhD lives to bring the beneficial technologies at the intersection of science, medicine, and engineering into as many lives as possible.
Dr. Moncivais began that work at Rice University where she engineered living cellular stents to express anti-clotting agents while completing her BS in Bioengineering. She used her graduate studies to dive into the world of stem cell differentiation and protein engineering, which led her to Texas-based startup company Celling Biosciences at the completion of her PhD. There, she was part of the engineering team responsible for creating one of the most innovative bone marrow concentration devices on the market and pioneered workflow solutions and best practices that still define many of the most successful regenerative medicine practices.
Dr. Moncivais has been an independent regenerative medicine consultant since 2017 and spends her days partnering with innovative physicians, practices, and hospitals as they bring autologous, regenerative medicine technologies into their service offerings. She provides scientific, marketing, and operations guidance alongside an enthusiastically infectious passion for all things regenerative medicine. She has a BS, MS, and PhD in Bioengineering and has published and made more presentations on regenerative medicine than she can count.
- Pettine, K. A., Suzuki, R. K., Murphy, M. B., Moncivais, K., & Malur, M. AUTOLOGOUS BONE MARROW CONCENTRATE (BMC) FOR THE TREATMENT OF OSTEOARTHRITIS (OA) OF THE KNEE, HIP, AND SHOULDER IN FORMER NFL PLAYERS. J Stem Cell Res Ther. 2018;4(1). doi:10.15406/jsrt.2018.04.00106
- Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013). Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Experimental & molecular medicine, 45(11), e54.